The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis.
J Bone Miner Metab
; 35(1): 91-98, 2017 Jan.
Article
in En
| MEDLINE
| ID: mdl-26762133
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Osteoporosis
/
Bone Density
/
Teriparatide
/
Diphosphonates
/
Denosumab
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Bone Miner Metab
Journal subject:
METABOLISMO
Year:
2017
Document type:
Article
Affiliation country:
Japan
Country of publication:
Japan